Table 3.

Lipids enhanced the classification of NASH patients as derived from the XGBoost algorithm.

		Total Population			NASH			Control–NAFL
	p-Value	Median	95% Lower CI	95% Upper CI	Median	95% Lower CI	95% Upper CI	Median	95% Lower CI	95% Upper CI
HOMA-IR	2.61 × 10−4	3.50	2.20	4.80	6.10	4.80	8.95	2.2	1.70	2.90
BMI (kg/m2)	1.04 × 10−2	29.3	25.7	31.2	31.6	28.5	35.3	26.0	24.4	30.4
Platelets (×103) (K/μL)	1.87 × 10−1	226	205	251	216	172	253	226	207	274
LDL (mg/dL )	8.10 × 10−1	101	82.0	121	96.0	80.0	121	101	77.0	126
Ferritin (ng/mL)	2.62 × 10−2	149	98.7	218	200	132	569	101	76.0	163
AST (U/L)	8.47 × 10−5	27.0	23.0	35.0	43.5	35.5	52.5	22.0	20.0	27.0
FA 12:0 (μΜ)	5.50 × 10−4	73.4	71.7	74.0	75.2	73.8	86.7	71.7	71.2	73.4
FA 18:3 ω3 (μΜ)	1.11 × 10−3	66.0	65.2	68.9	70.8	66.9	81.5	65.3	64.7	66.0
FA 20:4 ω6/ FA 20:5 ω3	4.79 × 10−1	5.86	5.74	6.14	5.79	5.51	6.20	5.92	5.66	6.27
CAR 4:0 (μΜ)	4.18 × 10−1	0.09	0.07	0.11	0.11	0.09	0.13	0.07	0.07	0.11
LPC(20:4) (μΜ)	9.60 × 10−3	7.99	6.71	8.75	6.16	5.07	7.81	8.66	7.99	9.76
LPC(O-16:1) (μΜ)	3.25 × 10−1	0.74	0.68	0.85	0.73	0.67	0.86	0.77	0.67	1.00
LPE(18:0) (μΜ)	7.95 × 10−2	2.43	1.97	2.86	2.53	2.28	3.44	2.02	1.90	2.88
DG(18:1_18:2) (μΜ)	8.19 × 10−3	15.2	12.6	18.0	22.0	17.5	35.2	13.0	12.3	16.5
CE 20:4 (μΜ)	4.00 × 10−4	957	766	1056	664	564	783	1056	957	1295